TriangleFOR PATIENTS · SOURCE READING
Immunotherapy
Source: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment may be used:
Immunotherapy helps a person's immune system fight cancer. Types of immunotherapy include:
CAR T-cell therapy changes the patient's T cells (a type of immune system cell) so they will attack certain proteins on the surface of cancer cells. T cells are taken from the patient and special receptors are added to their surface in the laboratory. The changed cells are called chimeric antigen receptor (CAR) T cells. The CAR T cells are grown in the laboratory and given to the patient by infusion. The CAR T cells multiply in the patient's blood and attack cancer cells. CAR T-cell therapy is being studied in the treatment of Burkitt lymphoma and diffuse large B-cell lymphoma that has not responded to treatment or has recurred (come back).
Source links and citations
Cyclosporine A is used in combination with steroids to treat subcutaneous panniculitic T-cell lymphoma.
Source links and citations
Learn more about Immunotherapy to Treat Cancer.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice